Workup of a Pancreatic Mass
For a suspected pancreatic mass, obtain a dedicated pancreatic protocol CT scan with multiphase contrast enhancement as the primary diagnostic and staging modality 1, 2, 3, 4.
Initial Imaging Strategy
The cornerstone of pancreatic mass evaluation is contrast-enhanced CT using a defined pancreas protocol that includes:
- Non-contrast phase plus arterial, pancreatic parenchymal, and portal venous phases
- Thin cuts (≤3mm) through the abdomen
- This technique allows precise visualization of tumor-vessel relationships and detection of metastases as small as 3-5mm 1
CT of the chest should be included to evaluate for pulmonary metastases 2, 3.
When CT Shows a Mass
If CT demonstrates a pancreatic mass:
- No biopsy is needed if the lesion appears resectable and you plan immediate surgery 5, 6, 1
- Proceed directly to multidisciplinary surgical consultation at a high-volume center (performing ≥15-20 pancreatic resections annually) 1, 2
- Avoid percutaneous biopsy in potentially resectable cases due to risk of peritoneal seeding 6, 1
When CT Shows No Mass or Is Equivocal
If CT is negative or inconclusive despite clinical suspicion:
- Perform endoscopic ultrasound (EUS) - this has 98% sensitivity for detecting pancreatic lesions and is superior for tumors <2cm 7, 8
- EUS can be combined with fine-needle aspiration (FNA) if tissue diagnosis is needed 1
- MRI with MRCP is an alternative, particularly useful for isoattenuating tumors (5-17% of cases) that are invisible on CT 3
When Tissue Diagnosis Is Required
Biopsy is mandatory only in these specific situations 5, 6:
- Unresectable disease where you need confirmation before chemotherapy
- When neoadjuvant treatment is planned
- Metastatic lesions present
For tissue acquisition, use EUS-guided FNA rather than percutaneous biopsy in potentially resectable cases - it has better diagnostic yield, safety profile, and lower risk of peritoneal seeding 1.
Additional Staging Considerations
Laparoscopy
Consider diagnostic laparoscopy selectively 5, 7, 1:
- For body/tail tumors (higher risk of occult metastases)
- When CA 19-9 is markedly elevated
- For large tumors or borderline resectable disease
- Before planned neoadjuvant therapy
- Laparoscopy detects occult peritoneal/liver metastases in up to 25% of cases, changing management 5
MRI Role
MRI is more sensitive than CT for detecting small liver metastases, identifying lesions missed by CT in 10-23% of cases 3. Consider MRI in high-risk patients to reduce unnecessary laparotomy.
PET/CT
PET/CT is NOT routinely recommended 6, 2, 3:
- Cannot reliably distinguish cancer from chronic/autoimmune pancreatitis
- Not a substitute for high-quality pancreatic protocol CT
- May be considered as adjunct in highly selected high-risk patients after formal CT protocol 1
Critical Pitfalls to Avoid
Do not perform preoperative biliary stenting routinely - a recent trial showed substantial increase in serious complications when stenting before surgery 6. Only stent if surgery must be significantly delayed.
Do not let a negative biopsy delay surgery when clinical suspicion is high - false negatives occur 7.
Do not use ultrasound alone - it cannot visualize the entire pancreas and has 20-25% technical failure rate due to bowel gas 7.
Do not order angiography - vascular information is obtained non-invasively with CT/MRI 7.
Laboratory Testing
- CA 19-9 has limited diagnostic value but obtain baseline level 6, 3
- Not specific for pancreatic cancer
- Falsely elevated in cholestasis/jaundice
- 5-10% of population lacks Lewis antigen and cannot produce CA 19-9
- Useful for monitoring treatment response and prognosis once diagnosis established
Clinical Red Flags Suggesting Unresectability
These findings typically indicate incurable disease 7:
- Persistent back pain
- Marked, rapid weight loss
- Palpable abdominal mass
- Ascites
- Supraclavicular lymphadenopathy
Special Populations
Consider pancreatic cancer in 7:
- New-onset diabetes without predisposing features or family history (occurs in up to 10% as first presentation) 5
- Unexplained acute pancreatitis episode
Obtain family history and consider genetic counseling for young patients, those with family cancer history, or Ashkenazi Jewish ancestry 2.